
Feasibility and Safety of Anlotinib Plus Docetaxel versus Docetaxel Monotherapy in Patients with Previously ...
Introduction Lung cancer remains the leading cause of cancer-related mortality worldwide with over 2.48 million new cases and approximately 1.82 million deaths each year.1 Non-small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancer …